Production of IL-1β, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE

Autoimmunity

Volumn 30, Issue 4, 1999, Pages 235-242

  Andersen, Lis S ^a   Petersen, JØrgen ^a   Svenson, Morten ^a   Bendtzen, Klaus ^a  

^a University of Copenhagen   (Denmark)

Author keywords

IgG; IL 10; IL 1ra; IL 1 ; Lipopolysaccharide; Mononuclear cells; SLE

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; MITOGENIC AGENT; SIALOGLYCOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; AGED; BIOSYNTHESIS; BLOOD; CELL CULTURE; CYTOLOGY; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; MONOCYTE;

ADULT; AGED; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MITOGENS; MONOCYTES; SIALOGLYCOPROTEINS;

EID: 0032589465     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908993804     Document Type: Article

References (33)

1. B.L. Kotzin, Systemic lupus erythematosus. Cell 1996; 85: 303-306.
2. G.J. Fournie, Circulating DNA and lupus nephritis. Kidney Int. 1988; 33: 487-497.
3. C.G. Cochrane and D. Koffler, Immune complex disease in experimental animals and man. Adv. Immunol. 1973; 16: 185-264.
4. K. Bendtzen, Cytokines and natural regulators of cytokines. Immunol. Lett. 1994; 43: 111-123.
5. W.P. Arend, Interleukin-1 receptor antagonist. Adv. Immunol. 1993; 54: 167-227.
6. H.Y. Lan, Therapeutic effects of cytokine blockade in glomerulonephritis (editorial). Nephrol. Dial. Transplant. 1998; 13: 7-9.
7. W.P. Arend, F.G. Joslin and R.J. Massoni, Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor J. Immunol. 1985; 134: 386-3875.
8. P.H. Schur, D.M. Chang, P. Baptiste, L.C. Uhteg and D.C. Hanson, Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals. Clin. immunol. Immunopathol. 1990; 57: 45-63.
9. J.E. Salmon, R.P. Kimberly, A. Gibofsky and M. Fontino, Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor ligand binding and internalization. J Immunol. 1984; 133: 2525-2531.
10. A.I.F. Blakemore, J.K. Tarlow, M.J. Cork, C. Gordon, P. Emery and G.W. Duff, Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 1994; 37: 1380-1385.
11. L. Llorente, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, M.C. Maillot, I, Durand-Gasselin et al., Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cvtokine Netw. 1993; 4: 421-427.
12. P.D. Katsikis, C.-Q. Chu, F.M. Brennan, R.N. Maini and M. Feldmann, Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 1994; 179: 1517-1527.
13. E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield et al. The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum. 1982; 25:1271-1277.
14. M.H. Liang, S.A. Socher, M.G. Larson and P.H. Schur, Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989; 32: 1107-1118.
15. L.S. Andersen, J. Petersen, M. Svenson and K. Bendtzen, IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: An in vitro phenomenon depending upon plastic adherence. Autoimmunity 1995; 22: 127-133.
16. D.J. Herzyk, A.E. Berger, J.N. Allen and M.D. Wewers, Sandwich ELISA formats designed to detect 17kDa IL-1β significantly underestimate 35kDa IL-1β. J. Immunol. Methods 1992; 148: 243-254.
17. H. Suzuki, H. Takemura and H. Kashiwagi, Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus: Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum. 1995; 38: 1055-1059.
18. S.C. Hsieh, C.Y. Tsai, K.H. Sun, Y.Y. Tsai, S.T. Tsai, S.H. Han et al., Defective spontaneous and bacterial lipopolysaccharide-stimulated production of interleukin-1 receptor antagonist by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Br. J. Rheumatol. 1995; 34: 107-112.
19. G. Kaplan and G. Gaudernack, In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J. Exp. Med. 1982; 156: 1101-1114.
20. S.L. Newman and M.A. Tucci, Regulation off human monocyte/macrophage function by extracellular matrix. Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function. J. Clin. Invest. 1990; 86: 703-714.
21. J.E. Salmon, S. Kapur, N.L. Meryhew, O.A. Runquist and R.P. Kimberly, High-dose, pulse intravenous methyl-prednisolone enhances Fc gamma receptor-mediated mononuclear phagocyte function in systemic lupus erythematosus. Arthritis Rheum. 1989; 32: 717-725.
22. M. Kavai, I. Csipo, I. Sonkoly, J. Csongor and G.Y. Szegedi, Detective immune complex degradation by monocytes in patients with systemic lupus erythematosus. Scand. J. Immunol. 1986; 24: 527-532.
23. P. Kastnre, H. Franke, P. Kleinert, C. Gunther, K. Malberg and M. Lobnitz (Fc-receptor mediated immune complex clearance function of the mononuclear phagocyte system in systemic lupus erythematosus. Allerg Immunol. 1990; 36: 103-110.
24. J. Vazquez-Doval and A. Sanchez-Ibarrola, Defective mononuclear phagocyte function in systemic lupus erythematosus: Relationship of FcRII (CD32) with intermediate cytoskeletal filaments. J. Investig. Allergol. Clin. Immunol. 1993; 3: 86-91
25. J.E. Salmon, R.P. Kimberly, A. Gibofsky and M. Fotino, Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fe gamma receptor specific. J. Immunol 1986; 136: 3625-3630.
26. T.R. Fields, E.N. Gerardi, B. Ghebrehiwet, R.S. Bennett, T.J. Lawley, R.P. Hall et al., Reticuloendothelial system fc receptor function in rheumatoid arthritis. J. Rheumatol. 1983; 10: 550-557.
27. M. Linker-Israeli, A.C. Bakke, R.C. Kitridou, S. Gendler, S. Gillis and D.A. Horwitz, Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 1983; 130: 2651-2655.
28. R. Phillips, R. Lomnitzer and A.R. Rabson, Modulation of the sodium periodate (NaIO4) response in systemic lupus erythematosus (SLE): Effect of interleukin-1 (IL-1), interleukin-2 (IL-2), phorbol myristate acetate (PMA), and indomethacin. Clin. Immunol. Immunopathol. 1985; 34: 77-83.
29. S. Sierakowski, E.J. Kucharz, R.W. Lightfoot Jr. and J.S. Goodwin, Interleukin-1-production by monocytes from patients with systemic lupus erythematosus. Clin. Rheumatol. 1987; 6: 403-407.
30. J. Alcocer-Varela and D. Alarcon-Segovia, Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosis. Rheumatol. Int. 1995; 15: 57-63.
31. P.J. Knudsen, C.A. Dinarello and T.B. Strom, Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J. Immunol 1987; 139: 4129-4134.
32. N. Goes, J. Urmson, V. Ramassar and P.F. Halloran, Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565-572.
33. R.D.W. Malefyt, J. Abrams, B. Bennett, C.G. Figdor and de J.E. Vries, Interteukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991; 174: 1209-1220.